• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利什曼病患者的临床与实验室分析:来自新德里一家三级医疗中心的回顾性研究

Clinical and Laboratory Analysis of Patients with Leishmaniasis: A Retrospective Study from a Tertiary Care Center in New Delhi.

作者信息

Gupta Nitin, Kant Kamla, Mirdha Bijay Ranjan

机构信息

Dept. of Medicine and Microbiology, All India Institute of Medical Sciences, New Delhi, India.

Dept. of Microbiology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Iran J Parasitol. 2017 Oct-Dec;12(4):632-637.

PMID:29317889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5756314/
Abstract

BACKGROUND

Leishmaniasis manifests as visceral (VL), cutaneous (CL) or a dermal sequel of VL, known as Post kala-azar dermal leishmaniasis (PKDL). The aim of the study was to analyze the clinical and laboratory features of cases diagnosed with leishmaniasis.

METHODS

This hospital-based retrospective study included all cases of VL, PKDL, and CL diagnosed between Jan 2011 to Jan 2016 at All India Institute of Medical Sciences, New Delhi. Clinical and laboratory profile of the diagnosed cases were analyzed in detail. All diagnosed cases were mapped according to the state and the district from which the cases originated.

RESULTS

A total of 91 VL cases and 4 PKDL cases were reviewed. Only one case of CL (1 female) and mucocutaneous leishmaniasis (1 female) were observed during the study period. Majority of the cases of VL (75/91) originated from Bihar. The most common presenting symptoms in all our patients were fever (97.8%), weight loss (40.6%) and abdominal discomfort (17.6%) while the most common presenting signs were hepatosplenomegaly (45.8%), isolated splenomegaly (23.1%) and skin pigmentation (11%). The most common laboratory abnormality was anaemia followed by thrombocytopenia and leucopenia.

CONCLUSION

VL is globally recognized as a neglected tropical disease. Even after continued effort to bring down its transmission in India, it continues to affect the endemic states with reports from new pockets.

摘要

背景

利什曼病表现为内脏型(VL)、皮肤型(CL)或VL的皮肤后遗症,即黑热病后皮肤利什曼病(PKDL)。本研究的目的是分析诊断为利什曼病的病例的临床和实验室特征。

方法

这项基于医院的回顾性研究纳入了2011年1月至2016年1月在新德里全印度医学科学研究所诊断的所有VL、PKDL和CL病例。对确诊病例的临床和实验室资料进行了详细分析。所有确诊病例均根据病例来源的邦和地区进行了定位。

结果

共回顾了91例VL病例和4例PKDL病例。在研究期间仅观察到1例CL(1名女性)和黏膜皮肤利什曼病(1名女性)。大多数VL病例(75/91)来自比哈尔邦。我们所有患者最常见的症状是发热(97.8%)、体重减轻(40.6%)和腹部不适(17.6%),而最常见的体征是肝脾肿大(45.8%)、单纯脾肿大(23.1%)和皮肤色素沉着(11%)。最常见的实验室异常是贫血,其次是血小板减少和白细胞减少。

结论

VL在全球被公认为一种被忽视的热带病。即使在印度持续努力降低其传播率之后,它仍继续影响着流行邦,并有来自新地区的报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8567/5756314/4b47b95d5c72/IJPA-12-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8567/5756314/eceb62dd64ed/IJPA-12-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8567/5756314/4b47b95d5c72/IJPA-12-632-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8567/5756314/eceb62dd64ed/IJPA-12-632-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8567/5756314/4b47b95d5c72/IJPA-12-632-g002.jpg

相似文献

1
Clinical and Laboratory Analysis of Patients with Leishmaniasis: A Retrospective Study from a Tertiary Care Center in New Delhi.利什曼病患者的临床与实验室分析:来自新德里一家三级医疗中心的回顾性研究
Iran J Parasitol. 2017 Oct-Dec;12(4):632-637.
2
Post Kala-Azar dermal leishmaniasis following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India.在印度比哈尔邦,采用20毫克/千克脂质体两性霉素B(安必素)治疗原发性内脏利什曼病后出现的黑热病后皮肤利什曼病。
PLoS Negl Trop Dis. 2014 Jan 2;8(1):e2611. doi: 10.1371/journal.pntd.0002611. eCollection 2014.
3
Longitudinal Study of Transmission in Households with Visceral Leishmaniasis, Asymptomatic Infections and PKDL in Highly Endemic Villages in Bihar, India.印度比哈尔邦高度流行村庄内脏利什曼病、无症状感染和皮肤利什曼病后黑热病家庭传播的纵向研究
PLoS Negl Trop Dis. 2016 Dec 14;10(12):e0005196. doi: 10.1371/journal.pntd.0005196. eCollection 2016 Dec.
4
Improved kala-azar case management through implementation of health facility-based sentinel sites surveillance system in Bihar, India.通过在印度比哈尔邦实施基于卫生机构的哨点监测系统,改善黑热病病例管理。
PLoS Negl Trop Dis. 2021 Aug 24;15(8):e0009598. doi: 10.1371/journal.pntd.0009598. eCollection 2021 Aug.
5
Visceral Leishmaniasis-HIV Coinfection as a Predictor of Increased Transmission at the Village Level in Bihar, India.内脏利什曼病-人类免疫缺陷病毒合并感染是印度比哈尔邦村庄层面传播增加的预测因素。
Front Cell Infect Microbiol. 2021 Mar 11;11:604117. doi: 10.3389/fcimb.2021.604117. eCollection 2021.
6
Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India.印度比哈尔邦内脏利什曼病流行地区的黑热病后皮肤利什曼病。
Trop Med Int Health. 2012 Nov;17(11):1345-8. doi: 10.1111/j.1365-3156.2012.03067.x. Epub 2012 Aug 12.
7
PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.合并感染HIV的利什曼病患者的皮肤利什曼病后皮肤黏膜病变及其他皮肤病变:与免疫反应相关的临床表现综述
PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3258. doi: 10.1371/journal.pntd.0003258. eCollection 2014.
8
Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012.2012 年 6 月 27 日至 29 日,印度新德里举行了无黑热病皮肤利什曼病(PKDL)联合会议报告。
Parasit Vectors. 2013 Jul 2;6:196. doi: 10.1186/1756-3305-6-196.
9
Utility of smear examination, culture, and serological tests in the diagnosis of visceral leishmaniasis/post-kala-azar dermal leishmaniasis at National Centre for Disease Control, Delhi.德里国家疾病控制中心涂片检查、培养及血清学检测在内脏利什曼病/黑热病后皮肤利什曼病诊断中的应用
Trop Parasitol. 2022 Jan-Jun;12(1):54-58. doi: 10.4103/tp.tp_7_21. Epub 2022 Jun 26.
10
The usefulness of trained field workers in diagnosis of post-kala-azar dermal leishmaniasis (PKDL) and clinico-epidemiological profile in highly endemic areas of Bihar.培训过的现场工作者在诊断卡拉-阿扎尔后皮肤利什曼病(PKDL)中的作用以及比哈尔邦高度流行地区的临床流行病学特征。
Trans R Soc Trop Med Hyg. 2019 Jun 1;113(6):332-340. doi: 10.1093/trstmh/trz007.

引用本文的文献

1
Diagnostic accuracy of serological rk-39 test for visceral Leishmaniasis: Systematic review and meta-analysis.血清 rk-39 试验诊断内脏利什曼病的准确性:系统评价和荟萃分析。
PLoS Negl Trop Dis. 2024 Mar 6;18(3):e0011938. doi: 10.1371/journal.pntd.0011938. eCollection 2024 Mar.
2
Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.2000年至2021年全球报告的人间非地方性利什曼病——一项全面综述
Pathogens. 2022 Aug 16;11(8):921. doi: 10.3390/pathogens11080921.
3
Hematological profiles of visceral leishmaniasis patients before and after treatment of anti-leishmanial drugs at University of Gondar Hospital; Leishmania Research and Treatment Center Northwest, Ethiopia.

本文引用的文献

1
Role of Haematological Changes in Predicting Occurrence of Leishmaniasis- A Study in Kumaon Region of Uttarakhand.血液学变化在预测利什曼病发生中的作用——北阿坎德邦库马翁地区的一项研究
J Clin Diagn Res. 2016 May;10(5):EC39-43. doi: 10.7860/JCDR/2016/15438.7885. Epub 2016 May 1.
2
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.从公共卫生角度看印度内脏利什曼病治疗方案的当前挑战
Infect Dis Poverty. 2016 Mar 8;5:19. doi: 10.1186/s40249-016-0112-2.
3
Developments in Diagnosis of Visceral Leishmaniasis in the Elimination Era.
埃塞俄比亚贡德尔大学医院和西北利什曼病研究与治疗中心在使用抗利什曼原虫药物治疗前后内脏利什曼病患者的血液学特征。
BMC Infect Dis. 2021 Sep 26;21(1):1005. doi: 10.1186/s12879-021-06691-7.
4
Clinical and laboratory profiles of visceral leishmaniasis among adult patients admitted to Felege Hiwot Hospital, Bahir Dar, Ethiopia.埃塞俄比亚巴赫达尔市费莱格·希沃特医院收治的成年内脏利什曼病患者的临床和实验室特征
SAGE Open Med. 2021 Jul 31;9:20503121211036787. doi: 10.1177/20503121211036787. eCollection 2021.
消除时代内脏利什曼病的诊断进展
J Parasitol Res. 2015;2015:239469. doi: 10.1155/2015/239469. Epub 2015 Dec 30.
4
Social and Economic Burden of Human Leishmaniasis.人类利什曼病的社会和经济负担
Am J Trop Med Hyg. 2016 Mar;94(3):489-93. doi: 10.4269/ajtmh.15-0408. Epub 2016 Jan 19.
5
Clinico-epidemiological analysis of Post kala-azar dermal leishmaniasis (PKDL) cases in India over last two decades: a hospital based retrospective study.过去二十年印度黑热病后皮肤利什曼病(PKDL)病例的临床流行病学分析:一项基于医院的回顾性研究
BMC Public Health. 2015 Oct 26;15:1092. doi: 10.1186/s12889-015-2424-8.
6
Mucocutaneous leishmaniasis caused by Leishmania donovani infection in an Indian man.一名印度男子因杜氏利什曼原虫感染引发皮肤黏膜利什曼病。
Int J Dermatol. 2015 Jun;54(6):680-4. doi: 10.1111/ijd.12748. Epub 2014 Dec 29.
7
Kala-azar--a case series from non endemic area, Uttarakhand.黑热病——来自北阿坎德邦非流行地区的病例系列
J Commun Dis. 2012 Sep;44(3):145-9.
8
Diagnosis of leishmaniasis.利什曼病的诊断。
J Infect Dev Ctries. 2014 Aug 13;8(8):961-72. doi: 10.3855/jidc.4310.
9
Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features.伊朗的内脏利什曼病:流行病学与临床特征综述
Iran J Parasitol. 2013 Jul;8(3):348-58.
10
Clinico-hematological profile of visceral leishmaniasis among immunocompetent patients.免疫功能正常患者内脏利什曼病的临床血液学特征
Southeast Asian J Trop Med Public Health. 2013 Mar;44(2):143-9.